Effects of furosemide on renal calcium handling

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 4, 2007, Pages

  Lee, Chien Te ^a,b   Chen, Hung Chun ^b   Lai, Li Wen ^c   Yong, Kim Chong ^c   Lien, Yeong Hau H ^c,d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Calbindin D28k; Calbindin D9k; Thiazides; TRPV5; TRPV6

Indexed keywords

CALBINDIN; CHLOROTHIAZIDE; FUROSEMIDE; GENTAMICIN;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM EXCRETION; CALCIUM TRANSPORT; CALCIUM URINE LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FLUID INTAKE; HEMATOCRIT; HYPERCALCEMIA; KIDNEY TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; UPREGULATION; URINALYSIS; URINARY EXCRETION;

EID: 35348924295     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00038.2007     Document Type: Article

References (30)

1. --cotransporter abundance: role of aldosterone. J Am Soc Nephrol 12: 1335-1341, 2001.
2. Bilezikian JP. Management of acute hypercalcemia. N Engl J Med 326: 1196-1203, 1993.
3. Biner HL, Arpin-Bott MP, Loffing J, Wang X, Knepper M, Hebert SC, Kaissling B. Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol 13: 836-847, 2002.
4. Bushinsky DA, Favus MJ, Langman CB, Coe FL. Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption. Am J Physiol Renal Fluid Electrolyte Physiol 251: F17-F24, 1986.
5. Cheng CJ, Shiang JC, Hsu YJ, Yang SS, Lin SH. Hypocalciuria in patients with Gitelman syndrome: role of blood volume. Am J Kidney Dis 49: 693-700, 2007.
6. Ellison DH. Diuretic drug and the treatment of edema: from clinic to bench and back again. Am J Kidney Dis 23: 623-643, 1994.
7. Ezzedeen F, Adelman R, Ahifors C. Renal calcification in preterm infants: pathophysiology and long-term sequelae. J Pediatr 113: 532-539, 1988.
8. Fernandez P, Santos F, Gomez C, Cabeza JM, Rodriguez J, Rey C, Crespo M. Influence of three different types of hypercalciuria on bone. An experimental study. Pediatr Nephrol 13: 396-400, 1999.
9. Friedman PA, Bushinsky DA. Diuretic effects on calcium metabolism. Semin Nephrol 19: 551-556, 1999.
10. Gratny LL, Ringer K, Hall RT, Alon US. Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat. Biol Neonate 71: 37-45, 1997.
11. Greenberg A. Diuretic complications. Am J Med Sci 319: 10-24, 2000.
12. Hebert SC. Molecular mechanisms. Semin Nephrol 19: 504-523, 1999.
13. Hemmingsen C, Staun M, Meibom K, Bang K, Olgaard K. Urinary calcium excretion and renal calbindin-D28k. Kidney Blood Press Res 20: 247-250, 1997.
14. 3-responsive epithelia. J Biol Chem 274: 8375-8378, 1999.
15. 2+ channels in health and disease. J Am Soc Nephrol 16: 15-26, 2005.
16. Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 70: 360-363, 1982.
17. Kaissling B, Bachmann S, Kriz W. Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol Renal Fluid Electrolyte Physiol 248: F374-F381, 1985.
18. Kaissling B, Stanton BA. Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol Renal Fluid Electrolyte Physiol 255: F1256-F1268, 1988.
19. Lee CT, Huynh VM, Lai LW, Lien YH. Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice. Kidney Int 62: 2055-2061, 2002.
20. Lee CT, Shang S, Lai LW, Yong KC, Lien YH. Effect of thiazide on renal gene expression of apical calcium channels and calbindins. Am J Physiol Renal Physiol 287: F1164-F1170, 2004.
21. Lee CT, Lien YH, Lai LW, Chen JB, Lin CR, Chen HC. Increased renal calcium and magnesium transporter abundance in streptozotocin-induced diabetes mellitus. Kidney Int 69: 1786-1791, 2006.
22. Massey LK, Whiting SJ. Dietary salt, urinary calcium, and bone loss. J Bone Miner Res 11: 731-736, 1996.
23. 2+ channel TRPV6 in the kidney. J Am Soc Nephrol 14: 2731-2740, 2003.
24. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115: 1651-1658, 2005.
25. Parsons PP, Garland HO, Harpur ES, Old S. Acute gentamicin-induced hypercalciuria and hypermagnesiuria in the rat: dose-response relationship and role of renal tubular injury. Br J Pharmacol 122: 570-576, 1997.
26. Peng JB, Chen XZ, Berger UV, Vassilev PM, Brown EM, Hediger MA. A Rat kidney-specific calcium transporter in the distal nephron. J Biol Chem 275: 28186-28194, 2000.
27. Quamme GA. Effect of furosemide on calcium and magnesium transport in the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 241: F340-F347, 1981.
28. Rizzo M, Metafora S, Morelli F, Russo F, Ciani F, Capasso G. Chronic administration of bumetanide upregulates calbindin D28k mRNA and protein abundance in rat distal convoluted tubules. Nephron Physiol 97: 16-22, 2004.
29. Rose BD. Diuretics. Kidney Int 39: 336-352, 1991.
30. Simon DB, Lifton R. The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndromes. Am J Physiol Renal Fluid Electrolyte Physiol 271: F961-F966, 1996.